Observational, multicentre study to evaluate the effectiveness in routine clinical practice of Lanreotide Autogel 120 mg at extended dosing intervals (>4 weeks) for the treatment of acromegaly: SOMACROL study

Álvarez, CristinaFajardo-Montañana, CarmenMarazuela, MónicaCordido, FernandoVenegas Moreno, EvaPablos Velasco, Pedro dePiedrola Maroto, GonzaloOlvera Márquez, María del PilarPavón de Paz, IsabelCarvalho, DavideRomero, CarmenDe la Cruz, GuillermoBernabeu Morón, Ignacio2019-02-122019-02-122018-05Álvarez Escolá C, Fajardo C, Marazuela M, et al. Observational, multicentre study to evaluate the effectiveness in routine clinical practice of Lanreotide Autogel 120 mg at extended dosing intervals (>4 weeks) for the treatment of acromegaly: SOMACROL study. En: 20th European Congress of Endocrinology; 2018 May 19-22; Barcelona, Spain. Bristol, UK: Bioscientifica; 2018. p. GP11 (Endocr Abstr. 2018; 56)1479-6848http://hdl.handle.net/2183/21715Guided posterThis is not the definitive version of record of this article. This manuscript has been accepted for publication in Endocrine Abstracts, but the version presneted here has not yet been copy-edited, formatted or proofed. Consequently, Bioscientifca accepts no responsability for any errors or omissions it may contain. The definitive version in now freely avaliable at Bioscientifica web page.engObservational, multicentre study to evaluate the effectiveness in routine clinical practice of Lanreotide Autogel 120 mg at extended dosing intervals (>4 weeks) for the treatment of acromegaly: SOMACROL studyconference outputopen access